A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19
Clinical trial NCT06147063 · COMPLETED
Trial details
- NCT number
- NCT06147063
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2024-04-30
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.